Table 2.
Liver tests in patients with cholelithiasis and cholecystitis who underwent cholecystectomy
| Variable (normal range) |
CBD stones (90) |
No CBD stones (96) |
P-value1 | ||
| mean ± SD (range) | Incidence of abnormal results | mean ± SD (range) | Incidence of abnormal results | ||
| AST (5-35 IU/L) | 137.2 ± 131.8 (19-693) | 84.40% (76/90) | 62.9 ± 96.9 (10-670) | 41.67% (40/96) | < 0.001 |
| ALT (5-30 IU/L) | 178.7 ± 159.0 (17-696) | 95.55% (86/90) | 83.8 ± 109.5 (12-566) | 51.04% (49/96) | < 0.001 |
| ALK-P (40-133 IU/L) | 204.7 ± 122.7 (14-672) | 71.11% (64/90) | 118.8 ± 92.5 (38-615) | 22.92% (22/96) | < 0.001 |
| D. Bilirubin (0.0-0.4 mg/dL) | 2.16 ± 2.08 (0.1-12) | 88.89% (80/90) | 0.64 ± 1.01 (0-5.0) | 32.29% (31/96) | < 0.001 |
| T. Bilirubin (0.2-1.3 mg/dL) | 3.81 ± 3.27 (0.3-18.6) | 76.67% (69/90) | 1.50 ± 1.68 (0.2-9.3) | 27.08% (26/96) | < 0.001 |
1
Statistical analysis using the Student’s t-test. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALK-P: Alkaline phosphatase; D.: Direct; T.: Total.